• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 3. Acetyl protected thiol methacrylic polymers as effective ligands to keep quantum dots in luminescent standby mode?
  Marta Liras,Isabel Quijada-Garrido,Marta Palacios-Cuesta,Sonia Mu?oz-Durieux,Olga García Polym. Chem., 2014,5, 433-442
• 4. An investigation on the interaction modes of a single-strand DNA aptamer and RBP4 protein: a molecular dynamic simulations approach?
  Raheleh Torabi,Hedayatollah Ghourchian,Massoud Amanlou Org. Biomol. Chem., 2016,14, 8141-8153
• 5. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Organic phosphonic acids and derivatives

Recent Advances in the Study of Ethyl Phosphonoformate (CAS: 102831-46-9) in Chemical Biology and Pharmaceutical Research

Ethyl phosphonoformate (CAS: 102831-46-9) is a phosphonate derivative that has garnered significant attention in chemical biology and pharmaceutical research due to its unique biochemical properties and potential therapeutic applications. Recent studies have explored its role as an enzyme inhibitor, particularly targeting viral polymerases and other key enzymes involved in disease pathways. This research brief synthesizes the latest findings on ethyl phosphonoformate, highlighting its mechanisms of action, synthetic applications, and emerging therapeutic potential.

One of the most notable applications of ethyl phosphonoformate is its function as a potent inhibitor of viral RNA and DNA polymerases. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy against the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2, suggesting its potential as a broad-spectrum antiviral agent. The study utilized crystallographic analysis to elucidate the binding interactions between ethyl phosphonoformate and the active site of RdRp, providing a structural basis for further drug optimization.

In addition to its antiviral properties, ethyl phosphonoformate has been investigated for its role in modulating cellular signaling pathways. Research published in Nature Chemical Biology in early 2024 revealed its ability to selectively inhibit phosphotransferase enzymes, which are critical in the regulation of metabolic and inflammatory responses. This finding opens new avenues for the development of targeted therapies for metabolic disorders and autoimmune diseases.

The synthetic utility of ethyl phosphonoformate has also been a focus of recent investigations. A study in Organic Letters (2023) described its use as a versatile building block in the synthesis of phosphonate-based prodrugs, which exhibit enhanced bioavailability and tissue specificity. The researchers highlighted its compatibility with modern click chemistry techniques, enabling the rapid assembly of complex molecular architectures for drug discovery.

Despite these promising developments, challenges remain in the clinical translation of ethyl phosphonoformate-based therapies. Issues such as metabolic stability, off-target effects, and formulation optimization are currently being addressed in preclinical studies. Collaborative efforts between academic and industrial researchers are expected to accelerate the progression of these compounds into clinical trials.

In conclusion, ethyl phosphonoformate (CAS: 102831-46-9) represents a multifaceted tool in chemical biology and pharmaceutical research. Its dual role as an enzyme inhibitor and synthetic intermediate underscores its versatility, while ongoing studies continue to expand its therapeutic potential. Future research should focus on overcoming translational barriers and exploring novel applications in precision medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)